The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity

The cost‐effectiveness of pharmacotherapy and lifestyle intervention in the treatment of obesity

Summary Background The Food and Drug Administration has approved several pharmacotherapies for the treatment of obesity. This study assesses the cost‐effectiveness of six pharmacotherapies and lifestyle intervention for people with mild obesity (body mass indices [BMIs] 30 to 35). Methods A microsim...

Full description

Bibliographic Details
Main Authors: Minyi Lee, Brianna N. Lauren, Tiannan Zhan, Jin Choi, Matthew Klebanoff, Barham Abu Dayyeh, Elsie M. Taveras, Kathleen Corey, Lee Kaplan, Chin Hur
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Obesity Science & Practice
Subjects:
cost‐effectiveness analysis
obesity
pharmacotherapy
weight loss
Online Access:https://doi.org/10.1002/osp4.390

Similar Items

Similar Items